4.4 Article

The Lectin Complement Pathway in Patients with Necrotizing Soft Tissue Infection

Journal

JOURNAL OF INNATE IMMUNITY
Volume 8, Issue 5, Pages 507-516

Publisher

KARGER
DOI: 10.1159/000447327

Keywords

Sepsis; Mortality; Bacterial infection; Immunity

Categories

Funding

  1. European Union's Seventh Framework Program [305340]
  2. Rigshospitalet Research Foundation [E-22514-02]
  3. Aase and Ejnar Danielsens Foundation [10-001274]
  4. Hans and Nora Buchards Foundation [7334]
  5. Director Jacob Madsen and Olga Madsens Foundation [5323]
  6. Novo Nordisk Research Foundation (bmkk)
  7. Danish Heart Association Research Foundation [15-R99-A5943-22922]
  8. Novo Nordisk Fonden [NNF13SA0009309] Funding Source: researchfish

Ask authors/readers for more resources

Background: Mannose-binding lectin (MBL) and ficolins are pattern recognition molecules (PRMs) that play an important role during infection through activation of the lectin complement pathway. We assessed whether plasma PRM levels were associated with mortality in patients with necrotizing soft tissue infection (NSTI). Methods: We conducted a prospective, observational study over 25 months involving 135 NSTI patients with a maximum follow-up of 2.7 years. Blood samples were taken upon admission. Non-infected patients served as controls. Results: PRM levels were significantly lower compared with controls. A baseline Ficolin-2 level below the median was associated with mortality at the end of follow-up (p = 0.007). No significant association was found for MBL, Ficolin-1 and Ficolin-3. A Ficolin-2 level below the median had a negative predictive value of 0.94 for 28-day mortality, and a level below the optimal cut-off was independently associated with 28-day mortality when adjusted for age, sex and chronicity [hazard ratio 6.27 (95% confidence interval 2.28-17.21), p < 0.0001], also when Simplified Acute Physiology Score II was included in the analysis [hazard ratio 3.16 (95% confidence interval 1.03-9.73), p = 0.045]. Conclusions: All PRMs were significantly lower in patients with NSTI than in controls. Only baseline Ficolin-2 was associated with short- and long-term mortality. A high baseline Ficolin-2 level indicated a 94% chance of surviving the first 28 days after admission. (C) 2016 S. Karger AG, Basel

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available